EcoDrugPlus

Equilibrative Nucleoside Transporter 1-Like

Ensembl ID : ENSSPAG00000009521
Gene Symbol: LOC103370708
3 Cross references
209 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSSPAG00000012325
Gene Symbol: ERBB3
3 Cross references
211 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSSPAG00000014194
Gene Symbol: ERBB4
3 Cross references
230 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSSPAG00000018551
Gene Symbol: ERBB4
3 Cross references
47 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSSPAG00000004227
Gene Symbol: ESR1
3 Cross references
215 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSSPAG00000020701
Gene Symbol: LOC103368808
3 Cross references
198 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSSPAG00000009324
Gene Symbol: LOC103362926
3 Cross references
208 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSSPAG00000019409
Gene Symbol: ESRRG
1 Cross references
196 Possible Orthologues:

Estrogen-Related Receptor Gamma-Like

Ensembl ID : ENSSPAG00000016511
Gene Symbol: LOC103368684
3 Cross references
156 Possible Orthologues:

Exportin 1

Ensembl ID : ENSSPAG00000010307
Gene Symbol: XPO1
3 Cross references
224 Possible Orthologues:

Exportin 1

Ensembl ID : ENSSPAG00000008738
Gene Symbol: XPO1
3 Cross references
211 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSSPAG00000022468
Gene Symbol: FDPS
3 Cross references
267 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).